Urolithin A Stabilizes CPT1A to Promote HUWE1-Associated NCOA4 Degradation and Alleviate Glucocorticoid-Induced Osteonecrosis of the Femoral Head
Year: 2026
Type: review
Abstract: Glucocorticoid‑induced osteonecrosis of the femoral head (GIONFH) is characterized by impaired osteogenesis, lipid metabolic dysregulation, and trabecular collapse, but its molecular mechanisms remain unclear. This study identifies CPT1A‑mediated lipid metabolic homeostasis as a critical protective mechanism against glucocorticoid (GC)‑induced osteogenic injury and ferroptosis. Single‑cell analysis revealed reduced osteoblast abundance and altered lipid metabolism‑related pathways in bone tissue upon GC stimulation. Dexamethasone (DEX) was found to promote lipid deposition, lipid peroxidation, iron overload, mitochondrial impairment, and osteogenic inhibition in both in vitro and in vivo settings; overexpression of CPT1A, however, counteracted these pathological alterations and restored the microarchitecture of the femoral head. Mechanistically, CPT1A directly bound NCOA4 and promoted HUWE1‑mediated K48‑linked ubiquitination and proteasomal degradation of NCOA4, thereby limiting NCOA4‑dependent ferritinophagy and ferroptosis. Virtual screening combined with experimental validation identified urolithin A (UA) as a compound that targeted and stabilized CPT1A, enhanced HUWE1‑dependent NCOA4 degradation, suppressed lipid peroxidation and ferroptosis, and restored osteogenic function. Collectively, this study reveals a lipid metabolism-ubiquitination coupling mechanism underlying GIONFH pathogenesis and suggests that targeting CPT1A holds therapeutic potential.
Source: Pharmacological Research
Language: English
Topic: Bone and Joint Diseases
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Keywords: glucocorticoid-induced osteonecrosis of the femoral head, urolithin A, CPT1A, NCOA4, HUWE1, K48-linked ubiquitination, proteasomal degradation, ferroptosis, ferritinophagy, lipid metabolism, osteogenic differentiation, osteoblasts, dexamethasone, lipid peroxidation, iron overload, mitochondrial dysfunction
Open Access status: gold
Estimated APC paid: $4,130
OpenAlex ID: W7225340227
